In front of the REMEDI factory in India. /Courtesy of REMEDI

Radiation (X-ray) technology specialized corporations REMEDI(387690) is showing strength in early trading on its first day of listing on the KOSDAQ market, trading more than 30% above the offer price.

At 9:11 a.m. on the 13th on the KOSDAQ market, REMEDI is trading at 27,050 won, up 6,350 won (30.68%) from the offer price (20,700 won).

REMEDI is a corporations that has secured original technology in low-dose, miniaturized, high-definition X-ray. Building on this, it has successfully developed and commercialized medical portable X-ray devices, industrial non-destructive testing (NDT) equipment, and core X-ray components.

In particular, it has completed a "full-stack" technology system that can carry out the entire process in-house, from designing key components required for X-ray generators to producing the final finished goods. It is currently expanding its business to special-purpose markets as well as medical and industrial.

REMEDI holds a platform technology that simultaneously overcomes the inherent technical limits of X-ray equipment—low dose, miniaturization, and high definition. Centered on low-dose, high-definition implementation technology and lightweight, miniaturized generation technology, it has also accumulated 10 original technologies. It is expanding into a diverse product lineup, including not only medical X-ray equipment but also industrial non-destructive testing equipment, tubes, emitters, and high-voltage generators.

※ This article has been translated by AI. Share your feedback here.